Cyclin D1 inhibits mitochondrial activity in B cells

Cancer Research

Volumn 71, Issue 5, 2011, Pages 1690-1699

  Tchakarska, Guergana ^a   Roussel, Mikel ^a   Troussard, Xavier ^a   Sola, Brigitte ^a  

^a CHU CÔTE DE NACRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; CYCLIN D1; HEXOKINASE; HEXOKINASE 2; HYBRID PROTEIN; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG; VOLTAGE DEPENDENT ANION CHANNEL;

ARTICLE; B LYMPHOCYTE; BREAST CARCINOGENESIS; BREAST EPITHELIUM; CELL ACTIVITY; CELL IMMORTALIZATION; CELL MATURATION; CELL METABOLISM; CELL PROLIFERATION; CELLULAR DISTRIBUTION; ENERGY YIELD; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MITOCHONDRIAL MEMBRANE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION;

B-LYMPHOCYTES; BLOTTING, WESTERN; CELL LINE; CELL PROLIFERATION; CELL SEPARATION; CYCLIN D1; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOPRECIPITATION; MEMBRANE POTENTIAL, MITOCHONDRIAL; MICROSCOPY, CONFOCAL; MITOCHONDRIA; RECOMBINANT FUSION PROTEINS;

EID: 79952233335     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-10-2564     Document Type: Article

References (41)

1. Sherr CJ, Roberts JM. Living with or without cyclins and cyclin-dependent kinases. Genes Dev 2004;18:2699-711. (Pubitemid 39507762)
2. Fu M, Wang C, Li Z, Sakamaki T, Pestell RG. Cyclin D1: normal and abnormal functions. Endocrinology 2004;145:5439-47.
3. Wang C, Li Z, Fu M, Bouras T, Pestell RG. Signal transduction mediated by cyclin D1: from mitogens to cell proliferation. A molecular target with therapeutic potential. Cancer Treat Res 2004;119:217-37.
4. Li Z, Wang C, Prendergast GC, Pestell RG. Cyclin D1 functions in cell migration. Cell Cycle 2006;5:2440-2. (Pubitemid 44785818)
5. Motokura T, Bloom T, Kim HG, Juppner H, Ruderman JV, Kronenberg HM, et al. A novel cyclin encoded by a bcl1-linked candidate oncogene. Nature 1991;350:512-5. (Pubitemid 21912266)
6. Knudsen KE, Diehl JA, Haiman CA, Knudsen ES. Cyclin D1: polymorphism, aberrant splicing and cancer risk. Oncogene 2006;25:1620-8.
7. Lamb J, Ramaswamy S, Ford HI, Contreras B, Martinez RV, Kittrell FS, et al. A mechanism of cyclin D1 action encoded in the patterns of gene expression in human cancer. Cell 2003;114:323-54.
8. Li Z, Wang C, Jiao X, Lu Y, Fu M, Quong AA, et al. Cyclin D1 regulates cellular migration through the inhibition of thrombospondin 1 and ROCK signaling. Mol Cell Biol 2006;26:4240-56. (Pubitemid 43788023)
9. Sakamaki T, Casimiro MC, Ju X, Quong AA, Katiyar S, Liu M, et al. Cyclin D1 determines mitochondrial function in vivo. Mol Cell Biol 2006;26:5449-69. (Pubitemid 44036212)
10. Jares P, Colomer D, Campo E. Genetic and molecular pathogenesis of mantle cell lymphoma: perspectives for new targeted therapeutics. Nat Rev Cancer 2007;7:750-62. (Pubitemid 47463673)
11. Bergsagel PL, Kuehl WM, Zhan F, Sawyer J, Barlogie B, Shaughnessy J Jr. Cyclin D dysregulation: an early and unifying pathogenic event in multiple myeloma. Blood 2005106;296-303.
12. Klier M, Anastasov N, Hermann A, Meindl T, Angermeier D, Raffeld M, et al. Specific lentiviral shRNA-mediated knockdown of cyclin D1 in mantle cell lymphoma has minimal effects on cell survival and reveals a regulatory circuit with cyclin D2. Leukemia 2008;2:2097-105.
13. Tchakarska G, Le Lan-leguen A, Roth L, Sola B. The targeting of the sole cyclin D1 is not adequate for mantle cell lymphoma and myeloma therapies. Haematologica 2009;94:1781-2.
14. Gump JM, Dowdy SF. TAT transduction: the molecular mechanism and the therapeutic prospects. Trends Mol Med 2005;13:443-8.
15. Schwarze SR, Hruska KA, Dowdy SF. Protein transduction: unrestricted delivery into all cells?Trends Cell Biol 2000;10:290-5.
16. Becker-Hapak M, McAllister SS, Dowdy SF. TAT-mediated protein transduction into mammalian cells. Methods 2001;24:247-56. (Pubitemid 32846431)
17. Marsaud V, Tchakarska G, Andrieux G, Liu J-M, Dembele D, Jost B, et al. Cyclin K and cyclin D1b are oncogenic in myeloma cells. Mol Cancer 2010;9:103.
18. Sakamaki T, Casimiro MC, Ju X, Quong AA, Katiyar S, Liu M, et al. Cyclin D1 determines mitochondrial function in vivo. Mol Cell Biol 2006;26:5449-69. (Pubitemid 44036212)
19. Cossarizza A, Baccarini-Contri M, Kalashnikova G, Franceschi C. A new method for the cytofluorometric analysis of mitochondrial membrane potential using the J-aggregate forming lipophilic cation 5,50,6,60 -tetrachloro - 1,10,3,30 -tetraethylbenzimidazolcarbocyanine iodide (JC-1). Biochem Biophys Res Comm 1993;197:40-5.
20. Lesage D, Lesage D, Troussard X, Sola B. The enigmatic role of cyclin D1 in multiple myeloma. Int J Cancer 2005;115:171-6. (Pubitemid 40586724)
21. Chiles TC. Regulation and function of cyclin D2 in B lymphocytes subsets. J Immunol 2004;173:2901-7. (Pubitemid 39141991)
22. Carthon BC, Neumann CA, Das M, Pawlyk B, Li T, Geng Y, et al. Genetic replacement of cyclin D1 function in mouse development by cyclin D2. Mol Cell Biol 2005;25:1081-8. (Pubitemid 40165814)
23. Diehl JA, Cheng M, Roussel MF, Sherr CJ. Inhibition of cyclin D1 phosphorylation on threonine-286 prevents its rapid degradation via the ubiquitin-proteasome pathway. Genes Dev 1997;11:957-72. (Pubitemid 27199876)
24. Alao JP, Gamble SC, Stavropoulou AV, Pomeranz KM, Lam EW, Coombes RC,et al. The cyclin D1 proto-oncogene is sequestered in the cytoplasm of mammalian cancer cell lines. Mol Cancer 2006;5:7.
25. Codogno P, Meijer AJ. Autophagy and signalling: their role in cell survival and cell death. Cell Death Differ 2005;Sup 2:1509-18. (Pubitemid 41553987)
26. Hinds PW, Dowdy SF, Ng Eaton E, Arnold A, Weinberg RA. Function of a human cyclin gene as an oncogene. Proc Natl Acad Sci U S A 1994;91:709-13. (Pubitemid 24041471)
27. Diehl JA, Sherr CJ. A dominant-negative cyclin D1 mutant prevents nuclear import of cyclin-dependent kinase 4 (CDK4) and its phosphorylation by CDK-activating kinase. Mol Cell Biol 1997;17:7362-74. (Pubitemid 27505965)
28. Gladden AB, Woolery R, Aggarwal P, Wasik MA, Diehl JA. Expression of constitutively nuclear cyclin D1 in murine lymphocytes induces B-cell lymphoma. Oncogene 2006;25:998-1007. (Pubitemid 43277008)
29. Shoshan-Barmatz V, Keinan N, Zaid H. Uncovering the role of VDAC in the regulation of cell life and death. J Bioenerg Biomembr 2008;40:183-91.
30. Lemasters JJ, Holmuhamedov E. Voltage-dependent anion channel (VDAC) as mitochondrial governator - Thinking outside the box. Biochim Biophys Acta 2006;1732:181-90. (Pubitemid 43006024)
31. Wilson J. Isozymes of mammalian hexokinase: structure, subcellular localization and metabolic function. J Exp Biol 2003;206:2049-57. (Pubitemid 36761808)
32. Hitomi M, Yang K, Stacey AW, Stacey DW. Phosphorylation of cyclin D1 regulated by ATM or ATR controls cell cycle. Mol Cell Biol 2008;28:5478-93.
33. Wang C, Li Z, Lu Y, Du R, Katiyar S, Yang J, et al. Cyclin D1 repression of nuclear respiratory factor 1 integrates nuclear DNA synthesis and mitochondrial function. Proc Natl Acad Sci U S A 2006;103:11567-72. (Pubitemid 44182492)
34. Wang C, Pattabiraman N, Zhou NJ, Fu M, Sakamaki T, Albanese C, et al. Cyclin D1 repression of peroxisome proliferator-activated receptor g expression and transactivation. Mol Cell Biol 2003;23:6159-73. (Pubitemid 37013094)
35. Fu M, Wang C, Rao M, Wu X, Bouras T, Zhang X, et al. Cyclin D1 represses p300 transactivation through a cyclin-dependent kinase-independent mechanism. J Biol Chem 2005;280:29728-42. (Pubitemid 41177050)
36. Schiewer MJ, Morey LM, Burd CJ, Liu Y, Merry DE, Ho S-M, et al. Cyclin D1 repressor domain mediates proliferation and survival in prostate cancer. Oncogene 2009;28:1016-27.
37. Abu-Hamad S, Sivan S, Shoshan-Barmatz V. The expression level of the voltage-dependent anion channel controls life and death of the cell. Proc Natl Acad Sci U S A 2006; 103:5787-92.
38. Rostovtseva TK, Sheldon KL, Hassanzadeh E, Monge C, Saks V, Bezrukov SM, et al. Tubulin binding blocks mitochondrial voltage-dependent anion channel and regulates respiration. Proc Natl Acad Sci U S A 2008;105:18746-51.
39. Galluzzi L, Kepp O, Tajeddine N, Kroemer G. Disruption of the hexokinase-VDAC complex for tumor therapy. Oncogene 2008;27: 4633-5.
40. Roué G, Pichereau V, Lincet H, Colomer D, Sola B. Cyclin D1 mediates resistance to apoptosis through upregulation of molecular chaperones and consequent redistribution of cell death regulators. Oncogene 2008;27:4909-20.
41. Arbel N, Shoshan-Barmatz V. Voltage-dependent anion channel 1- based peptides interact with Bcl-2 to prevent antiapoptotic activity. J Biol Chem 2010;285:6053-62.